Literature DB >> 9792104

Characterization of a folding intermediate from HIV-1 ribonuclease H.

G Kern1, T Handel, S Marqusee.   

Abstract

The RNase H domain from HIV-1 (HIV RNase H) encodes an essential retroviral activity. Refolding of the isolated HIV RNase H domain shows a kinetic intermediate detectable by stopped-flow far UV circular dichroism and pulse-labeling H/D exchange. In this intermediate, strands 1, 4, and 5 as well as helices A and D appear to be structured. Compared to its homolog from Escherichia coli, the rate limiting step in refolding of HIV RNase H appears closer to the native state. We have modeled this kinetic intermediate using a C-terminal deletion fragment lacking helix E. Like the kinetic intermediate, this variant folds rapidly and shows a decrease in stability. We propose that inhibition of the docking of helix E to this folding intermediate may present a novel strategy for anti HIV-1 therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792104      PMCID: PMC2143833          DOI: 10.1002/pro.5560071014

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  47 in total

1.  The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.

Authors:  D W Rodgers; S J Gamblin; B A Harris; S Ray; J S Culp; B Hellmig; D J Woolf; C Debouck; S C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

2.  Definition of amide protection factors for early kinetic intermediates in protein folding.

Authors:  W A Houry; J M Sauder; H Roder; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases.

Authors:  L M Babé; J Rosé; C S Craik
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725

5.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

6.  Investigating the role of conserved residue Asp134 in Escherichia coli ribonuclease HI by site-directed random mutagenesis.

Authors:  M Haruki; E Noguchi; C Nakai; Y Y Liu; M Oobatake; M Itaya; S Kanaya
Journal:  Eur J Biochem       Date:  1994-03-01

7.  Role of histidine 124 in the catalytic function of ribonuclease HI from Escherichia coli.

Authors:  Y Oda; M Yoshida; S Kanaya
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

8.  A kinetic analysis of the folding of human carbonic anhydrase II and its catalysis by cyclophilin.

Authors:  G Kern; D Kern; F X Schmid; G Fischer
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport.

Authors:  A Gow; V L Friedrich; R A Lazzarini
Journal:  J Neurosci Res       Date:  1994-04-01       Impact factor: 4.164

10.  Protein three-dimensional structure determination and sequence-specific assignment of 13C and 15N-separated NOE data. A novel real-space ab initio approach.

Authors:  P J Kraulis
Journal:  J Mol Biol       Date:  1994-11-04       Impact factor: 5.469

View more
  14 in total

Review 1.  Early events in protein folding explored by rapid mixing methods.

Authors:  Heinrich Roder; Kosuke Maki; Hong Cheng
Journal:  Chem Rev       Date:  2006-05       Impact factor: 60.622

2.  Binding thermodynamics of metal ions to HIV-1 ribonuclease H domain.

Authors:  Masayuki Oda; Zhaoyong Xi; Satomi Inaba; Ryan L Slack; Rieko Ishima
Journal:  J Therm Anal Calorim       Date:  2018-06-09       Impact factor: 4.626

3.  Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.

Authors:  Zhaoyong Xi; Zhengqiang Wang; Stefan G Sarafianos; Nataliya S Myshakina; Rieko Ishima
Journal:  ACS Infect Dis       Date:  2019-10-02       Impact factor: 5.084

4.  Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor.

Authors:  Qingguo Gong; Lakshmi Menon; Tatiana Ilina; Lena G Miller; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2010-11-29       Impact factor: 2.817

5.  Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.

Authors:  Martin T Christen; Lakshmi Menon; Nataliya S Myshakina; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2012-08-31       Impact factor: 2.817

6.  Unfolding the HIV-1 reverse transcriptase RNase H domain--how to lose a molecular tug-of-war.

Authors:  Xunhai Zheng; Lars C Pedersen; Scott A Gabel; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2016-01-14       Impact factor: 16.971

7.  The high-resolution NMR structure of the early folding intermediate of the Thermus thermophilus ribonuclease H.

Authors:  Zheng Zhou; Hanqiao Feng; Rodolfo Ghirlando; Yawen Bai
Journal:  J Mol Biol       Date:  2008-09-26       Impact factor: 5.469

8.  Early Folding Events, Local Interactions, and Conservation of Protein Backbone Rigidity.

Authors:  Rita Pancsa; Daniele Raimondi; Elisa Cilia; Wim F Vranken
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

9.  Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility.

Authors:  Alfonso De Simone; Anne Dhulesia; Gemma Soldi; Michele Vendruscolo; Shang-Te Danny Hsu; Fabrizio Chiti; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

10.  Metal and ligand binding to the HIV-RNase H active site are remotely monitored by Ile556.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2012-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.